Dosage & Administration Drug label Financial assistance

Fabrazyme

(agalsidase beta)

agalsidase beta 35 MG Injection [Fabrazyme]agalsidase beta 5 MG Injection [Fabrazyme]

NO BOXED WARNING

Dosage & administration

* The recommended dosage is 1 mg/kg body weight given every two weeks as an intravenous infusion.
* Ensure appropriate medical support is available when Fabrazyme is administered because of the potential for anaphylaxis and severe infusion-associated reactions.
* Administer antipyretics prior to infusion.
* See the full prescribing information for the recommended infusion rate.

drug label

Fabrazyme prescribing information

Contact Medical Science Liaison Report Adverse Event

financial assistance

Fabrazyme financial assistance options

Co-pay savings program

commercial only

Enroll in Patient Savings Program

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

Foundation programs

under insured

no insurance

goverment insurance

65+

Charitable Access Program (Phone number to request application form)

Learn More

Overview

Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned

Patient benefit

Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted

Patient eligibility

Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.

How to sign up

Patients submit proof of out-of-pocket drug costs to charities for reimbursement

patient education

Fabrazyme patient education

To share resource; ask patient to:

1.Pull out phone

2.Open camera

3.Scan QR code with camera

4.Tap link

Patient toolkit

About Fabrazyme

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Females With Fabry

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Patient Resources

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Learn More

Fabrazyme FAQs

How is the dosage of Fabrazyme?Fabrazyme is available in 2 dosages, including 35 mg Injection and 5 mg Injection

What does Fabrazyme treat?Fabrazyme treats Fabry Disease

What is Fabrazyme made of?Fabrazyme contains agalsidase beta which is a Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme

How Is Fabrazyme Administered?Fabrazyme is administered as a Injectable

FAQ Data Source

Fabrazyme

Dosage & administration

drug label

Fabrazyme prescribing information

financial assistance

Fabrazyme financial assistance options

Co-pay savings program

Foundation programs

patient education

Fabrazyme patient education

Patient toolkit

people also ask

Fabrazyme FAQs